Influenza vaccine

Influenza vaccine

 

Influenza is an acute, contagious respiratory disease caused by a flu virus. It is seasonal, most commonly occurring in the winter months, between December and March. Every year, millions of people are suffering from this disease in the world.

You can take preventive vaccinations against influenza virus for the 2018/2019 season at the Health Care Center “Vizim”.

The vaccination package includes:

  • Consultations with a general medicine
  • Vaccine
  • Vaccine application

The price of the vaccine package is 1.200,00 dinars.

 

Vaccination, the best protection against influenza

Influenza virus with pronounced pathogenic potential and virulence and with constant antigenic mutations, every year, causes epidemics and, occasionally, pandemics around the world. Each year, the epidemic affects 5% -15% of the world’s population, and fatal outcomes range from 250 000 to 500 000 people. Although most of the flu are pre-school and school children, the most risk for hospitalization, complications and death are infants, chronic patients and older than 65 years.

Vaccines are the safest way of individual and collective protection against influenza and other infectious diseases.

Protection is achieved after 2-3 weeks of vaccination
The vaccine consists of weakened or dead viruses or their parts
It contains antigens of three strains of virus – 2 strains type A I strain type B virus; this reduces the risk of flu by 70-90% in healthy people
It does not provide permanent immunity, so it must be vaccinated every year (immunity to homologous viruses takes 6-12 months)
Possible simultaneous administration with other vaccines
Since the vaccine adapts to new circulating viruses each year, influenza vaccine must also be repeated every year from mid-October to mid-November.
Vaccination is possible at the age of 6 months and older.

Vaccination efficacy

  • Healthy persons up to 65 years old 70-90%
  • Children from 2 to 6 years of age about 60%
  • Children from 7 to 14 years 78%
  • Older than 65 and chronic patients 40-60%
  • Reduction of pneumonia and hospitalization 60-78%
  • Reduction of fatal outcome to 80%

Vaccination

In influenza epidemics, the most common complications are caused by respiratory organs in the form of: acute bronchitis, primary viral pneumonia, secondary bacterial pneumonia, bronchiolitis, lung abscess, asthma exacerbation and middle ear inflammation. In chronic patients, flu is often the cause of the underlying disease, even with the failure of the function of diseased organs, and mortality in chronic patients is 50-100 times higher than in healthy people. Therefore, vaccination is the only, the right available safeguards against influenza.

Target groups for vaccination are:

  • All persons older than 6 months with chronic disorders of the cardiovascular and pulmonary system including asthma, with metabolic disorders and in particular diabetes, with kidney and liver dysfunction, blood diseases, malignancies and immunodeficiency including HIV
  • All persons older than 65 years of age
  • All persons placed in gerontological centers and social care institutions, including employees
  • All persons employed in health institutions
  • Persons employed in public services

The influenza vaccine is contraindicated for:

  • All people who have a marked allergy to egg proteins and chicken meat
  • People with severe allergy to previous doses of vaccine (neomycin, formaldehyde, etc.)
  • All children younger than 6 months
  • People who have suffered from Guillain-Barre syndrome
  • People with acute infection, until they feel good

Optimal time for immunization?

The optimum time for vaccination is during October and November. However, according to the latest recommendations, people who are at high risk of infection, and who have not been vaccinated, should receive the vaccine throughout the influenza season without the risk of side effects.

Sertificate for vaccine here